Alkermes price target lowered to $28 from $29 at BofA | Nasdaq

Alkermes Price Target Lowered To $28 From $29 At BofA | Nasdaq

1 week from now

Oct 25, 2024  · BofA analyst Jason Gerberry lowered the firm’s price target on Alkermes (ALKS) to $28 from $29 and keeps a Neutral rating on the shares. The company reported a relatively in …

nasdaq.com

Alkermes Price Target Raised To $31 From $28 At BofA | Nasdaq

1 week from now

2 days ago  · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

nasdaq.com

Bank Of America Securities Keeps Their Hold Rating On Alkermes …

1 week from now

3 days ago  · Alkermes has an analyst consensus of Moderate Buy, with a price target consensus of $36.36. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of …

businessinsider.com

ALKS Stock Price | Alkermes PLC Stock Quote (U.S.: Nasdaq)

1 week from now

Nov 7, 2024  · Alkermes price target lowered to $28 from $29 at BofA Oct. 25, 2024 at 10:03 a.m. ET on TipRanks.com Bank of America Securities Sticks to Its Hold Rating for Alkermes (ALKS)

marketwatch.com

Alkermes Price Target Raised To $31 From $28 At BofA

1 week from now

3 days ago  · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple ...

businessinsider.com

Alkermes (ALKS) Gets A Hold From J.P. Morgan - Markets Insider

1 week from now

Oct 26, 2024  · However, on the same day, Goldman Sachs maintained a Buy rating on Alkermes (NASDAQ: ALKS). ... Alkermes price target lowered to $28 from $29 at BofA;

businessinsider.com

Alkermes Price Target Raised To $40 From $35 At Mizuho | Nasdaq

1 week from now

2 days ago  · Mizuho raised the firm’s price target on Alkermes (ALKS) to $40 from $35 and keeps an Outperform rating on the shares. The firm assessed its forecast and conducted a sum-of …

nasdaq.com

What Is The Current Price Target And Forecast For Alkermes (ALKS)

1 week from now

Nov 6, 2024  · Based on short-term price targets offered by 13 analysts, the average price target for Alkermes comes to $32.62. The forecasts range from a low of $21.00 to a high of $43.00.

zacks.com

Alkermes Inc.: Strong Q3 Performance And Strategic Growth Drive …

1 week from now

Oct 27, 2024  · Alkermes price target lowered to $28 from $29 at BofA; Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald; Alkermes price target lowered to $30 from $32 …

businessinsider.com

Alkermes (ALKS) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago  · According to the 12 analysts' twelve-month price targets for Alkermes, the average price target is $35.42. The highest price target for ALKS is $50.00, while the lowest price …

marketbeat.com

Alkermes Plc (ALKS) Stock Forecast & Price Targets - Stock Analysis

1 week from now

NASDAQ: ALKS · Real-Time Price · USD. Watchlist Compare. 30.08 +1.22 (4.21%) ... The 11 analysts with 12-month price forecasts for Alkermes stock have an average target of 35, with a …

stockanalysis.com

Mizuho Boosts Alkermes (NASDAQ:ALKS) Price Target To $40.00

1 week from now

1 day ago  · Shares of NASDAQ ALKS opened at $28.35 on Wednesday. The company has a market capitalization of $4.59 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.98 and a beta of …

defenseworld.net

Alkermes Price Target Lowered To $30 From $32 At Goldman Sachs

1 week from now

Oct 25, 2024  · Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The company’s Q3 results included operating …

nasdaq.com

Alkermes: Balancing Near-Term Challenges With Long-Term …

1 week from now

Oct 25, 2024  · Alkermes price target lowered to $28 from $29 at BofA; ... Alkermes price target lowered to $28 from $29 at BofA. ... Nasdaq 100; Nasdaq Composite;

businessinsider.com

Alkermes (NASDAQ:ALKS) Given New $40.00 Price Target At …

1 week from now

2 days ago  · Shares of ALKS stock opened at $29.23 on Wednesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 3.03 and a current ratio of 3.45. Alkermes has a fifty-two …

marketbeat.com

Alkermes: Strong Buy Rating Amidst Short-term Challenges And …

1 week from now

Oct 25, 2024  · Alkermes price target lowered to $28 from $29 at BofA; Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald; Alkermes price target lowered to $30 from $32 …

businessinsider.com

Tyra Biosciences Price Target Lowered To $29 From $31 At BofA

1 week from now

3 days ago  · BofA lowered the firm’s price target on Tyra Biosciences (TYRA) to $29 from $31 and keeps a Buy rating on the shares. Tyra had "an uneventful" Q3 update, which is "unlikely …

nasdaq.com

Buy Rating Affirmed On Alkermes’s Stock Amid Strong Earnings …

1 week from now

Jan 25, 2024  · The associated price target is $35.00. Uy Ear of Mizuho Securities has given a Buy rating to Alkermes’s stock based on an anticipated earnings beat and positive 2024 guidance …

businessinsider.com

TD Cowen Sticks To Their Buy Rating For Alkermes (ALKS)

1 week from now

4 days ago  · The company has a one-year high of $32.88 and a one-year low of $22.06. Currently, Alkermes has an average volume of 1.67M. ... Alkermes price target lowered to $28 …

businessinsider.com

Biotech Alert: Searches Spiking For These Stocks Today - Nasdaq

1 week from now

Nov 7, 2024  · Scotiabank lowered the firm’s price target on Apellis to $30 from $35 and kept a Sector Perform rating on the shares. ... lost 8.2% of their body weight after 28 days, or 6.8% …

nasdaq.com